Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Cognition in schizophrenia.

Literature DB >> 11559481

Cognition in schizophrenia.

Abstract

Cognitive dysfunction has been described as a hallmark feature of schizophrenia since the first descriptions of the illness. Kraepelin described a number of features of the disorder that he thought reflected impairments in cognition and attention. He also speculated that cognitive impairments were mediated by neurobiologic dysfunction, specifically impairments in the functions of the frontal lobe. Since Kraepelin's time, there have been many changes in the general conceptions of schizophrenia, including ideas regarding the status and importance of cognitive impairment in the illness. Due to increased sophistication of neuropsychologic assessment and neuroimaging techniques, cognitive impairment has again has risen to the forefront of importance in terms of theories regarding the etiology and treatment of schizophrenia.

Entities: Disease

Mesh：

Year: 2001 PMID： 11559481 DOI： 10.1007/s11920-996-0038-7

Source DB: PubMed Journal: Curr Psychiatry Rep ISSN： 1523-3812 Impact factor: 5.285

42 in total

1. Prediction of work performance by clinical symptoms and cognitive skills in schizophrenic outpatients.

Authors: T Suslow; K Schonauer; P Ohrmann; B Eikelmann; T Reker
Journal: J Nerv Ment Dis Date: 2000-02 Impact factor: 2.254

Review 2. Cognitive impairment as a target for pharmacological treatment in schizophrenia.

Authors: M Davidson; R S Keefe
Journal: Schizophr Res Date: 1995-09 Impact factor: 4.939

3. Stability and course of neuropsychological deficits in schizophrenia.

Authors: R K Heaton; J A Gladsjo; B W Palmer; J Kuck; T D Marcotte; D V Jeste
Journal: Arch Gen Psychiatry Date: 2001-01

4. Premorbid performance IQ deficit in schizophrenia.

Authors: G P Amminger; M Schlögelhofer; T Lehner; S Looser Ott; M H Friedrich; H N Aschauer
Journal: Acta Psychiatr Scand Date: 2000-12 Impact factor: 6.392

5. Relationship of cognitive functioning, adaptive life skills, and negative symptom severity in poor-outcome geriatric schizophrenia patients.

Authors: S R McGurk; P J Moriarty; P D Harvey; M Parrella; L White; J Friedman; K L Davis
Journal: J Neuropsychiatry Clin Neurosci Date: 2000 Impact factor: 2.198

6. The effects of atypical antipsychotic drugs on neurocognitive impairment in schizophrenia: a review and meta-analysis.

Authors: R S Keefe; S G Silva; D O Perkins; J A Lieberman
Journal: Schizophr Bull Date: 1999 Impact factor: 9.306

7. Neuropsychological differences between first-admission schizophrenia and psychotic affective disorders.

Authors: R Mojtabai; E J Bromet; P D Harvey; G A Carlson; T J Craig; S Fennig
Journal: Am J Psychiatry Date: 2000-09 Impact factor: 18.112

8. Effects of atypical neuroleptics on sustained attention deficits in schizophrenia: a trial of risperidone versus haloperidol.

Authors: S K Liu; W J Chen; C J Chang; H N Lin
Journal: Neuropsychopharmacology Date: 2000-03 Impact factor: 7.853

Review 9. A review of longitudinal studies of cognitive functions in schizophrenia patients.

Authors: B R Rund
Journal: Schizophr Bull Date: 1998 Impact factor: 9.306

Review 10. The costs of schizophrenia. Assessing the burden.

Authors: A Rupp; S J Keith
Journal: Psychiatr Clin North Am Date: 1993-06

16 in total

1. A study of the construct validity of the Health Utilities Index Mark 3 (HUI3) in patients with schizophrenia.

Authors: Nan Luo; Boon-Kheng Seng; Julian Thumboo; David Feeny; Shu-Chuen Li
Journal: Qual Life Res Date: 2006-06 Impact factor: 4.147

2. Knockdown of Nurr1 in the rat hippocampus: implications to spatial discrimination learning and memory.

Authors: Wanda I Colón-Cesario; Michelle M Martínez-Montemayor; Sohaira Morales; Jahaira Félix; Juan Cruz; Monique Adorno; Lixmar Pereira; Nydia Colón; Carmen S Maldonado-Vlaar; Sandra Peña de Ortiz
Journal: Learn Mem Date: 2006 Nov-Dec Impact factor: 2.460

3. A normative chart for cognitive development in a genetically selected population.

Authors: Jacob Vorstman; Elemi J Breetvelt; Ania M Fiksinski; Carrie E Bearden; Anne S Bassett; René S Kahn; Janneke R Zinkstok; Stephen R Hooper; Wanda Tempelaar; Donna McDonald-McGinn; Ann Swillen; Beverly Emanuel; Bernice Morrow; Raquel Gur; Eva Chow; Marianne van den Bree; Joris Vermeesch; Stephen Warren; Michael Owen; Therese van Amelsvoort; Stephan Eliez; Doron Gothelf; Celso Arango; Wendy Kates; Tony Simon; Kieran Murphy; Gabriela Repetto; Damian Heine Suner; Stefano Vicari; Joseph Cubells; Marco Armando; Nicole Philip; Linda Campbell; Sixto Garcia-Minaur; Maude Schneider; Vandana Shashi
Journal: Neuropsychopharmacology Date: 2021-03-29 Impact factor: 8.294

Cognition in schizophrenia.

1. Prediction of work performance by clinical symptoms and cognitive skills in schizophrenic outpatients.

Review 2. Cognitive impairment as a target for pharmacological treatment in schizophrenia.

3. Stability and course of neuropsychological deficits in schizophrenia.

4. Premorbid performance IQ deficit in schizophrenia.

5. Relationship of cognitive functioning, adaptive life skills, and negative symptom severity in poor-outcome geriatric schizophrenia patients.

6. The effects of atypical antipsychotic drugs on neurocognitive impairment in schizophrenia: a review and meta-analysis.

7. Neuropsychological differences between first-admission schizophrenia and psychotic affective disorders.

8. Effects of atypical neuroleptics on sustained attention deficits in schizophrenia: a trial of risperidone versus haloperidol.

Review 9. A review of longitudinal studies of cognitive functions in schizophrenia patients.

Review 10. The costs of schizophrenia. Assessing the burden.

1. A study of the construct validity of the Health Utilities Index Mark 3 (HUI3) in patients with schizophrenia.

2. Knockdown of Nurr1 in the rat hippocampus: implications to spatial discrimination learning and memory.

3. A normative chart for cognitive development in a genetically selected population.

4. Cognitive dysfunction and associated factors in patients with chronic schizophrenia.

Review 5. Recent advances in treating cognitive impairment in schizophrenia.

6. The Brief Assessment of Cognition in Schizophrenia. Normative data for the Italian population.

7. Elevated GRIA1 mRNA expression in Layer II/III and V pyramidal cells of the DLPFC in schizophrenia.

Review 8. Prefrontal dopamine in associative learning and memory.

9. Serotonin modulation of cortical neurons and networks.

10. Cognitive functions in methamphetamine induced psychosis compared to schizophrenia and normal subjects.